Contact

All Stories

  1. Probenecid Treatment Inhibits Replication of the Edmonston Measles Virus Strain in Vero Cells

    Article • Viruses, November 2025, MDPI AG

    Professor Ralph A Tripp

  2. Restricting O-Linked Glycosylation of the Mucin-like Domains Enhances Immunogenicity and Protective Efficacy of a Respiratory Syncytial Virus G Glycoprotein Vaccine Antigen

    Article • Vaccines, September 2025, MDPI AG

    Professor Ralph A Tripp

  3. The MAPK Response to Virus Infection Is Modified by Probenecid

    Article • Current Issues in Molecular Biology, April 2025, MDPI AG

    Professor Ralph A Tripp

  4. Layer-by-Layer Microparticle Vaccines Containing a S177Q Point Mutation in the Central Conserved Domain of the RSV G Protein Improves Immunogenicity

    Article • Viral Immunology, April 2025, Mary Ann Liebert Inc

    Professor Ralph A Tripp

  5. Probenecid Inhibits NLRP3 Inflammasome Activity and Mitogen-Activated Protein Kinases (MAPKs)

    Article • Biomolecules, April 2025, MDPI AG

    Professor Ralph A Tripp

  6. Evaluating Probenecid or Oseltamivir Inhibition of Influenza A Virus Replication Through Plaque Assay or Fluorescent Focus Assay Using Non-Structural Protein 1–H1N1 Venus Reporter Virus

    Article • Viruses, February 2025, MDPI AG

    Professor Ralph A Tripp

  7. Probenecid Inhibits Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus Response

    Article • International Journal of Molecular Sciences, November 2024, MDPI AG

    Professor Ralph A Tripp

  8. Antiviral agents and therapeutics against respiratory viruses

    Article • Expert Opinion on Investigational Drugs, September 2024, Taylor & Francis

    Professor Ralph A Tripp

  9. Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice

    Article • Viruses, July 2024, MDPI AG

    Professor Ralph A Tripp

  10. mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge

    Article • PLOS One, April 2024, PLOS

    Professor Ralph A Tripp

  11. Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice

    Article • Viruses, January 2024, MDPI AG

    Professor Ralph A Tripp

  12. Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication

    Article • Viruses, November 2023, MDPI AG

    Professor Ralph A Tripp

  13. mRNA Vaccines Encoding Influenza Virus Hemagglutinin (HA) Elicits Immunity in Mice from Influenza A Virus Challenge

    Article • November 2023, Cold Spring Harbor Laboratory Press

    Professor Ralph A Tripp

  14. Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19

    Article • Viruses, November 2023, MDPI AG

    Professor Ralph A Tripp

  15. Understanding immunity to influenza: implications for future vaccine development

    Article • Expert Review of Vaccines, October 2023, Taylor & Francis

    Professor Ralph A Tripp

  16. Interferons—Implications in the Immune Response to Respiratory Viruses

    Article • Microorganisms, August 2023, MDPI AG

    Professor Ralph A Tripp

  17. Oral Probenecid for Nonhospitalized Adults with Symptomatic Mild-to-Moderate COVID-19

    Article • Viruses, July 2023, MDPI AG

    Professor Ralph A Tripp

  18. Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein

    Article • Viruses, April 2023, MDPI AG

    Professor Ralph A Tripp

  19. Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge

    Article • Vaccines, December 2022, MDPI AG

    Professor Ralph A Tripp

  20. RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein

    Article • Viruses, October 2022, MDPI AG

    Professor Ralph A Tripp

  21. Influenza B Virus (IBV) Immune-Mediated Disease in C57BL/6 Mice

    Article • Vaccines, September 2022, MDPI AG

    Professor Ralph A Tripp

  22. Isothermal amplification using sequence-specific fluorescence detection of SARS coronavirus 2 and variants in nasal swabs

    Article • BioTechniques, June 2022, Future Science

    Professor Ralph A Tripp

  23. Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication

    Article • Viruses, April 2022, MDPI AG

    Professor Ralph A Tripp

  24. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication

    Article • Viruses, March 2022, MDPI AG

    Professor Ralph A Tripp

  25. Structural basis for ultrapotent neutralization of human metapneumovirus

    Article • March 2022, Cold Spring Harbor Laboratory Press

    Professor Ralph A Tripp

  26. ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2

    Article • iScience, January 2022, Elsevier

    Professor Ralph A Tripp

  27. Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)

    Article • Expert Opinion on Investigational Drugs, December 2021, Taylor & Francis

    Professor Ralph A Tripp

  28. Immunopathology of RSV: An Updated Review

    Article • Viruses, December 2021, MDPI AG

    Professor Ralph A Tripp

  29. MicroRNAs affect GPCR and Ion channel genes needed for influenza replication

    Article • Journal of General Virology, November 2021, Society for General Microbiology

    Professor Ralph A Tripp

  30. Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro

    Article • PLOS One, October 2021, PLOS

    Professor Ralph A Tripp

  31. Advances in Vaccine Development

    Article • Vaccines, September 2021, MDPI AG

    Professor Ralph A Tripp

  32. Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs

    Article • PLOS One, September 2021, PLOS

    Professor Ralph A Tripp

  33. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein

    Article • Journal of Virology, August 2021, ASM Journals

    Professor Ralph A Tripp

  34. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo

    Article • Antiviral Research, August 2021, Elsevier

    Professor Ralph A Tripp

  35. Losartan Inhibits SARS-CoV-2 Replication in Vitro

    Article • Journal of Pharmacy & Pharmaceutical Sciences, July 2021, Frontiers

    Professor Ralph A Tripp

  36. Innate Antiviral Cytokine Response to Swine Influenza Virus by Swine Respiratory Epithelial Cells

    Article • Journal of Virology, July 2021, ASM Journals

    Professor Ralph A Tripp

  37. Probenecid Inhibits SARS-CoV-2 Replication In Vivo and In Vitro

    Article • May 2021, Cold Spring Harbor Laboratory Press

    Professor Ralph A Tripp

  38. G-Protein-Coupled Receptor and Ion Channel Genes Used by Influenza Virus for Replication

    Article • Journal of Virology, April 2021, ASM Journals

    Professor Ralph A Tripp

  39. Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins

    Article • Viruses, April 2021, MDPI AG

    Professor Ralph A Tripp

  40. Losartan promotes cell survival following SARS-CoV-2 infection in vitro

    Article • December 2020, Cold Spring Harbor Laboratory Press

    Professor Ralph A Tripp

  41. Innate and adaptive immune responses in respiratory virus infection: implications for the clinic

    Article • Expert Review of Respiratory Medicine, September 2020, Taylor & Francis

    Professor Ralph A Tripp

  42. Exosome-mediated human norovirus infection

    Article • PLOS One, August 2020, PLOS

    Professor Ralph A Tripp

  43. Pathobiology of Respiratory Syncytial Virus (RSV)

    Article • Vaccines, July 2020, MDPI AG

    Professor Ralph A Tripp

  44. Regulation of Mumps Virus Replication and Transcription by Kinase RPS6KB1

    Article • Journal of Virology, June 2020, ASM Journals

    Professor Ralph A Tripp

  45. Up-to-date role of biologics in the management of respiratory syncytial virus

    Article • Expert Opinion on Biological Therapy, April 2020, Taylor & Francis

    Professor Ralph A Tripp

  46. Vero Cells as a Mammalian Cell Substrate for Human Norovirus

    Article • Viruses, April 2020, MDPI AG

    Professor Ralph A Tripp

  47. Emerging small and large molecule therapeutics for respiratory syncytial virus

    Article • Expert Opinion on Investigational Drugs, February 2020, Taylor & Francis

    Professor Ralph A Tripp

  48. Gene-edited vero cells as rotavirus vaccine substrates

    Article • Vaccine X, December 2019, Elsevier

    Professor Ralph A Tripp

  49. Original Antigenic Sin and Respiratory Syncytial Virus Vaccines

    Article • Vaccines, September 2019, MDPI AG

    Professor Ralph A Tripp

  50. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus In Vivo

    Article • Journal of Virology, July 2019, ASM Journals

    Professor Ralph A Tripp

  51. Human Norovirus: Experimental Models of Infection

    Article • Viruses, February 2019, MDPI AG

    Professor Ralph A Tripp

  52. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro

    Article • Journal of Virology, December 2018, ASM Journals

    Professor Ralph A Tripp

  53. Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model

    Article • Antiviral Research, June 2018, Elsevier

    Professor Ralph A Tripp

  54. Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses

    Article • Antimicrobial Agents and Chemotherapy, March 2018, ASM Journals

    Professor Ralph A Tripp

  55. Viral Modulation of Host Translation and Implications for Vaccine Development

    Article • February 2018, IntechOpen

    Professor Ralph A Tripp

  56. Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses

    Article • Viruses, January 2018, MDPI AG

    Professor Ralph A Tripp

  57. A universal mammalian vaccine cell line substrate

    Article • PLOS One, November 2017, PLOS

    Professor Ralph A Tripp

  58. Revisiting the RSV G protein as a target for drugs and vaccines.

    Article • Journal of Virology, November 2017, ASM Journals

    Prof. Ultan F Power, Professor Ralph A Tripp

  59. MicroRNA-134 regulates poliovirus replication by IRES targeting

    Article • Scientific Reports, October 2017, Nature

    Professor Ralph A Tripp

  60. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge

    Article • Journal of Virology, September 2017, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  61. The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection

    Article • Vaccines, July 2017, MDPI AG

    Professor Ralph A Tripp

  62. Respiratory syncytial virus: prospects for new and emerging therapeutics

    Article • Expert Review of Respiratory Medicine, June 2017, Taylor & Francis

    Professor Ralph A Tripp

  63. Enhanced immunogenicity following miR-155 incorporation into the influenza A virus genome

    Article • Virus Research, May 2017, Elsevier

    Professor Ralph A Tripp

  64. Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment

    Article • Clinical & Translational Immunology, March 2017, Wiley

    Professor Ralph A Tripp

  65. Development of improved vaccine cell lines against rotavirus

    Article • Scientific Data, March 2017, Springer Science + Business Media

    Professor Ralph A Tripp

  66. Roles of Non-coding RNAs in Respiratory Syncytial Virus (RSV) Infection

    Article • January 2017, Springer Science + Business Media

    Professor Ralph A Tripp

  67. Inhaled Countermeasures for Respiratory Tract Viruses

    Article • December 2016, Taylor & Francis

    Professor Ralph A Tripp

  68. Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus

    Article • Vaccines, December 2016, MDPI AG

    Professor Ralph A Tripp

  69. Passive narcosis for anesthesia induction in cotton rats (Sigmodon hispidus)

    Article • Lab Animal, September 2016, Nature

    Professor Ralph A Tripp

  70. Development of a Zika vaccine

    Article • Expert Review of Vaccines, June 2016, Taylor & Francis

    Professor Ralph A Tripp

  71. MicroRNA-555 has potent antiviral properties against poliovirus

    Article • Journal of General Virology, March 2016, Society for General Microbiology

    Professor Ralph A Tripp

  72. Human Respiratory Syncytial Virus

    Article • January 2016, Springer Science + Business Media

    Professor Ralph A Tripp

  73. MicroRNA Profiling from RSV-Infected Biofluids, Whole Blood, and Tissue Samples

    Article • January 2016, Springer Science + Business Media

    Professor Ralph A Tripp

  74. Quantification of RSV Infectious Particles by Plaque Assay and Immunostaining Assay

    Article • January 2016, Springer Science + Business Media

    Professor Ralph A Tripp

  75. Human Respiratory Syncytial Virus: An Introduction

    Article • January 2016, Springer Science + Business Media

    Professor Ralph A Tripp

  76. Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis

    Article • Expert Review of Vaccines, December 2015, Taylor & Francis

    Professor Ralph A Tripp

  77. Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease

    Article • Vaccines, October 2015, MDPI AG

    Professor Ralph A Tripp

  78. An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection

    Article • September 2015, European Respiratory Society (ERS)

    Professor Ralph A Tripp

  79. Antiviral agents for influenza virus

    Article • May 2015, Future Medicine

    Professor Ralph A Tripp

  80. Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression

    Article • Journal of Virology, March 2015, ASM Journals

    Professor Ralph A Tripp

  81. Polymerase Discordance in Novel Swine Influenza H3N2v Constellations Is Tolerated in Swine but Not Human Respiratory Epithelial Cells

    Article • PLOS One, October 2014, PLOS

    Professor Ralph A Tripp

  82. Can an influenza A-based delivery system overcome current challenges associated with miRNA technology?

    Article • Future Virology, October 2014, Future Medicine

    Professor Ralph A Tripp

  83. Frontiers in RNAi

    Article • September 2014, Bentham Science Publishers

    Professor Ralph A Tripp

  84. Preface

    Article • September 2014, Bentham Science Publishers

    Professor Ralph A Tripp

  85. List of Contributors

    Article • September 2014, Bentham Science Publishers

    Professor Ralph A Tripp

  86. Acknowledgments

    Article • September 2014, Bentham Science Publishers

    Professor Ralph A Tripp

  87. Author Index

    Article • September 2014, Bentham Science Publishers

    Professor Ralph A Tripp

  88. RNAi Screening to Facilitate Drug Repurposing

    Article • September 2014, Bentham Science Publishers

    Professor Ralph A Tripp

  89. Subject Index

    Article • September 2014, Bentham Science Publishers

    Professor Ralph A Tripp

  90. The Use of RNAi Technology in the Development of High Performance Bioproduction Cell Lines

    Article • September 2014, Bentham Science Publishers

    Professor Ralph A Tripp

  91. Virus-Vectored Influenza Virus Vaccines

    Article • Viruses, August 2014, MDPI AG

    Professor Ralph A Tripp

  92. Identification of Virulence Determinants in Influenza Viruses

    Article • Analytical Chemistry, June 2014, American Chemical Society (ACS)

    Professor Ralph A Tripp

  93. Verdinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces Influenza A Virus Replication In Vitro and In Vivo

    Article • Journal of Virology, June 2014, ASM Journals

    Professor Ralph A Tripp

  94. Rapid Identification of Bacterial Pathogens of Military Interest Using Surface-Enhanced Raman Spectroscopy

    Article • June 2014, Defense Technical Information Center (DTIC)

    Professor Ralph A Tripp

  95. A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5)

    Article • Vaccine, May 2014, Elsevier

    Professor Ralph A Tripp

  96. Indoleamine 2,3-Dioxygenase (IDO) Activity During the Primary Immune Response to Influenza Infection Modifies the Memory T Cell Response to Influenza Challenge

    Article • Viral Immunology, April 2014, Mary Ann Liebert Inc

    Stephen Mark Tompkins, Professor Ralph A Tripp

  97. Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets

    Article • mAbs, January 2014, Taylor & Francis

    Professor Ralph A Tripp

  98. Addressing the Re-emergence of Poliovirus

    Article • Journal of Antivirals & Antiretrovirals, January 2014, OMICS Publishing Group

    Professor Ralph A Tripp

  99. Antiviral Effects of Inhibiting Host Gene Expression

    Article • January 2014, Springer Science + Business Media

    Professor Ralph A Tripp

  100. Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice

    Article • PLOS One, December 2013, PLOS

    Professor Ralph A Tripp

  101. Targeting Fungal Genes by Diced siRNAs: A Rapid Tool to Decipher Gene Function in Aspergillus nidulans

    Article • PLOS One, October 2013, PLOS

    Professor Ralph A Tripp

  102. Targeting Cell Division Cycle 25 Homolog B To Regulate Influenza Virus Replication

    Article • Journal of Virology, October 2013, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  103. Modeling Respiratory Syncytial Virus Cytopathogenesis in the Human Airway

    Article • American Review of Respiratory Disease, October 2013, American Thoracic Society

    Professor Ralph A Tripp

  104. Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease

    Article • PLOS One, September 2013, PLOS

    Professor Ralph A Tripp

  105. Respiratory Syncytial Virus Infection Induces Higher Toll-Like Receptor-3 Expression and TNF-α Production Than Human Metapneumovirus Infection

    Article • PLOS One, September 2013, PLOS

    Professor Ralph A Tripp

  106. Viral Etiology and Clinical Profiles of Children with Severe Acute Respiratory Infections in China

    Article • PLOS One, August 2013, PLOS

    Professor Ralph A Tripp

  107. Protective Efficacy and Immunogenicity of a Combinatory DNA Vaccine against Influenza A Virus and the Respiratory Syncytial Virus

    Article • PLOS One, August 2013, PLOS

    Professor Ralph A Tripp

  108. Methotrexate Treatment Causes Early Onset of Disease in a Mouse Model of Ross River Virus-Induced Inflammatory Disease through Increased Monocyte Production

    Article • PLOS One, August 2013, PLOS

    Professor Ralph A Tripp

  109. A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles

    Article • PLOS One, August 2013, PLOS

    Professor Ralph A Tripp

  110. Gain-of-Function Experiments on H7N9

    Article • Science, August 2013, American Association for the Advancement of Science

    Professor Ralph A Tripp

  111. Gain-of-Function Experiments on H7N9

    Article • Science, August 2013, American Association for the Advancement of Science

    Professor Ralph A Tripp

  112. Advances in and the potential of vaccines for respiratory syncytial virus

    Article • Expert Review of Respiratory Medicine, August 2013, Taylor & Francis

    Professor Ralph A Tripp

  113. A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV

    Article • Journal of Virology, July 2013, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  114. Porcine Reproductive and Respiratory Syndrome Virus Nonstructural Protein 4 Induces Apoptosis Dependent on Its 3C-Like Serine Protease Activity

    Article • PLOS One, July 2013, PLOS

    Professor Ralph A Tripp

  115. Antiviral Responses by Swine Primary Bronchoepithelial Cells Are Limited Compared to Human Bronchoepithelial Cells Following Influenza Virus Infection

    Article • PLOS One, July 2013, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  116. Broadening the Heterologous Cross-Neutralizing Antibody Inducing Ability of Porcine Reproductive and Respiratory Syndrome Virus by Breeding the GP4 or M genes

    Article • PLOS One, June 2013, PLOS

    Professor Ralph A Tripp

  117. Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs

    Article • PLOS One, June 2013, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  118. Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection

    Article • PLOS One, June 2013, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  119. A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment

    Article • PLOS One, June 2013, PLOS

    Professor Ralph A Tripp

  120. The Role of Interleukin-1 and Interleukin-18 in Pro-Inflammatory and Anti-Viral Responses to Rhinovirus in Primary Bronchial Epithelial Cells

    Article • PLOS One, May 2013, PLOS

    Professor Ralph A Tripp

  121. Bat cells from Pteropus alecto are susceptible to influenza A virus infection and reassortment

    Article • Influenza and Other Respiratory Viruses, May 2013, Wiley

    Stephen Mark Tompkins, Professor Ralph A Tripp

  122. Vertical Transmission of Respiratory Syncytial Virus Modulates Pre- and Postnatal Innervation and Reactivity of Rat Airways

    Article • PLOS One, April 2013, PLOS

    Professor Ralph A Tripp

  123. Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice

    Article • Journal of General Virology, April 2013, Society for General Microbiology

    Stephen Mark Tompkins, Professor Ralph A Tripp

  124. Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection

    Article • Journal of General Virology, April 2013, Society for General Microbiology

    Stephen Mark Tompkins, Professor Ralph A Tripp

  125. Avian Influenza Virus Surveillance in Wild Birds in Georgia: 2009–2011

    Article • PLOS One, March 2013, PLOS

    Professor Ralph A Tripp

  126. Adenovirus 36, adiposity, and bone strength in late‐adolescent females

    Article • Journal of Bone and Mineral Research, February 2013, Oxford University Press (OUP)

    Stephen Mark Tompkins, Professor Ralph A Tripp

  127. siRNA Genome Screening Approaches to Therapeutic Drug Repositioning

    Article • Pharmaceuticals, January 2013, MDPI AG

    Professor Ralph A Tripp

  128. Transmission Studies Resume For Avian Flu

    Article • Science, January 2013, American Association for the Advancement of Science

    Professor Ralph A Tripp

  129. Detection and differentiation of foodborne pathogenic bacteria in mung bean sprouts using field deployable label-free SERS devices

    Article • The Analyst, January 2013, Royal Society of Chemistry

    Xiaomeng Wu, Professor Ralph A Tripp

  130. Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis

    Article • Immune Network, January 2013, The Korean Association of Immunobiologists (KAMJE)

    Professor Ralph A Tripp

  131. Risk Assessment and Anti-Viral Approaches for Novel H7N9 Influenza Virus

    Article • Journal of Antivirals & Antiretrovirals, January 2013, OMICS Publishing Group

    Professor Ralph A Tripp

  132. Therapeutic Considerations for Middle East Respiratory Syndrome Coronavirus

    Article • Journal of Antivirals & Antiretrovirals, January 2013, OMICS Publishing Group

    Professor Ralph A Tripp

  133. Host Gene Expression and Respiratory Syncytial Virus Infection

    Article • January 2013, Springer Science + Business Media

    Professor Ralph A Tripp

  134. Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice

    Article • PLOS One, December 2012, PLOS

    Professor Ralph A Tripp

  135. Infectious Diseases, Vibrational Spectroscopic Approaches to Rapid Diagnostics

    Article • December 2012, Springer Science + Business Media

    Professor Ralph A Tripp

  136. Enzymatically Produced Pools of Canonical and Dicer-Substrate siRNA Molecules Display Comparable Gene Silencing and Antiviral Activities against Herpes Simplex Virus

    Article • PLOS One, November 2012, PLOS

    Dr. Veijo I Hukkanen, Professor Ralph A Tripp

  137. Targeting Organic Anion Transporter 3 with Probenecid as a Novel Anti-Influenza A Virus Strategy

    Article • Antimicrobial Agents and Chemotherapy, November 2012, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  138. Highly Sensitive and Transparent Surface Enhanced Raman Scattering Substrates Made by Active Coldly Condensed Ag Nanorod Arrays

    Article • The Journal of Physical Chemistry C, September 2012, American Chemical Society (ACS)

    Professor Ralph A Tripp

  139. Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication

    Article • Journal of General Virology, August 2012, Society for General Microbiology

    Professor Ralph A Tripp

  140. Label-Free Detection of Micro-RNA Hybridization Using Surface-Enhanced Raman Spectroscopy and Least-Squares Analysis

    Article • Journal of the American Chemical Society, July 2012, American Chemical Society (ACS)

    Professor Ralph A Tripp

  141. Signal 3 Cytokines as Modulators of Primary Immune Responses during Infections: The Interplay of Type I IFN and IL-12 in CD8 T Cell Responses

    Article • PLOS One, July 2012, PLOS

    Professor Ralph A Tripp

  142. A New Model for Hendra Virus Encephalitis in the Mouse

    Article • PLOS One, July 2012, PLOS

    Professor Ralph A Tripp

  143. Nucleoprotein Nanostructures Combined with Adjuvants Adapted to the Neonatal Immune Context: A Candidate Mucosal RSV Vaccine

    Article • PLOS One, May 2012, PLOS

    Professor Ralph A Tripp

  144. MicroRNA Regulation of Human Protease Genes Essential for Influenza Virus Replication

    Article • PLOS One, May 2012, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  145. Antibodies to the Central Conserved Region of Respiratory Syncytial Virus (RSV) G Protein Block RSV G Protein CX3C-CX3CR1 Binding and Cross-Neutralize RSV A and B Strains

    Article • Viral Immunology, May 2012, Mary Ann Liebert Inc

    Professor Ralph A Tripp

  146. The use of a handheld Raman system for virus detection

    Article • May 2012, SPIE

    Professor Ralph A Tripp

  147. Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose

    Article • Vaccine, April 2012, Elsevier

    Stephen Mark Tompkins, Professor Ralph A Tripp

  148. Differential Expression of Cytokines in Response to Respiratory Syncytial Virus Infection of Calves with High or Low Circulating 25-Hydroxyvitamin D3

    Article • PLOS One, March 2012, PLOS

    Professor Ralph A Tripp

  149. Respiratory Syncytial Virus NS1 Protein Colocalizes with Mitochondrial Antiviral Signaling Protein MAVS following Infection

    Article • PLOS One, February 2012, PLOS

    Professor Ralph A Tripp

  150. The C Proteins of Human Parainfluenza Virus Type 1 Block IFN Signaling by Binding and Retaining Stat1 in Perinuclear Aggregates at the Late Endosome

    Article • PLOS One, February 2012, PLOS

    Professor Ralph A Tripp

  151. Pause on Avian Flu Transmission Research

    Article • Science, January 2012, American Association for the Advancement of Science

    Professor Ralph A Tripp

  152. Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens

    Article • The FASEB Journal, January 2012, Federation of American Societies For Experimental Biology (FASEB)

    Professor Ralph A Tripp

  153. Flexible and mechanical strain resistant large area SERS active substrates

    Article • Nanoscale, January 2012, Royal Society of Chemistry

    Professor Ralph A Tripp

  154. Infectious Diseases, Vibrational Spectroscopic Approaches to Rapid Diagnostics

    Article • January 2012, Springer Science + Business Media

    Professor Ralph A Tripp

  155. Current Progress on Surface-Enhanced Raman Scattering Chemical/Biological Sensing

    Article • January 2012, American Chemical Society (ACS)

    Professor Ralph A Tripp

  156. Surveillance of feral cats for influenza A virus in North Central Florida

    Article • Influenza and Other Respiratory Viruses, December 2011, Wiley

    Stephen Mark Tompkins, Professor Ralph A Tripp

  157. Detection and Differentiation of Avian Mycoplasmas by Surface-Enhanced Raman Spectroscopy Based on a Silver Nanorod Array

    Article • Applied and Environmental Microbiology, December 2011, ASM Journals

    Professor Ralph A Tripp

  158. Porcine FcγRIIb Mediates Enhancement of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection

    Article • PLOS One, December 2011, PLOS

    Professor Ralph A Tripp

  159. Humoral and Cell-Mediated Immunity to Pandemic H1N1 Influenza in a Canadian Cohort One Year Post-Pandemic: Implications for Vaccination

    Article • PLOS One, November 2011, PLOS

    Professor Ralph A Tripp

  160. Human Metapneumovirus: Lessons Learned over the First Decade

    Article • Clinical Microbiology Reviews, October 2011, ASM Journals

    Professor Oliver Schildgen, Professor Ralph A Tripp

  161. Increased MDSC Accumulation and Th2 Biased Response to Influenza A Virus Infection in the Absence of TLR7 in Mice

    Article • PLOS One, September 2011, PLOS

    Professor Ralph A Tripp

  162. Evidence Implicating the Ras Pathway in Multiple CD28 Costimulatory Functions in CD4+ T Cells

    Article • PLOS One, September 2011, PLOS

    Dr Sujit V Janardhan, Professor Ralph A Tripp

  163. Exposed Hydrophobic Residues in Human Immunodeficiency Virus Type 1 Vpr Helix-1 Are Important for Cell Cycle Arrest and Cell Death

    Article • PLOS One, September 2011, PLOS

    Professor Ralph A Tripp

  164. Evaluation of Protective Efficacy of Respiratory Syncytial Virus Vaccine against A and B Subgroup Human Isolates in Korea

    Article • PLOS One, September 2011, PLOS

    Professor Ralph A Tripp

  165. Influenza-Specific T Cells from Older People Are Enriched in the Late Effector Subset and Their Presence Inversely Correlates with Vaccine Response

    Article • PLOS One, August 2011, PLOS

    Professor Ralph A Tripp

  166. The Microbial Detection Array Combined with Random Phi29-Amplification Used as a Diagnostic Tool for Virus Detection in Clinical Samples

    Article • PLOS One, August 2011, PLOS

    Professor Ralph A Tripp

  167. Circulating Strains of Human Respiratory Syncytial Virus in Central and South America

    Article • PLOS One, August 2011, PLOS

    Professor Ralph A Tripp

  168. Interferon Production and Signaling Pathways Are Antagonized during Henipavirus Infection of Fruit Bat Cell Lines

    Article • PLOS One, July 2011, PLOS

    Professor Ralph A Tripp

  169. Immunostimulatory Motifs Enhance Antiviral siRNAs Targeting Highly Pathogenic Avian Influenza H5N1

    Article • PLOS One, July 2011, PLOS

    Professor Ralph A Tripp

  170. Avian Influenza Viruses Infect Primary Human Bronchial Epithelial Cells Unconstrained by Sialic Acid α2,3 Residues

    Article • PLOS One, June 2011, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  171. Self-Collected Mid-Turbinate Swabs for the Detection of Respiratory Viruses in Adults with Acute Respiratory Illnesses

    Article • PLOS One, June 2011, PLOS

    Dr Allison McGeer, Professor Ralph A Tripp

  172. Influenza A Virus Nucleoprotein Exploits Hsp40 to Inhibit PKR Activation

    Article • PLOS One, June 2011, PLOS

    Professor Ralph A Tripp

  173. Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors

    Article • PLOS One, June 2011, PLOS

    Professor Ralph A Tripp

  174. Polarity Changes in the Transmembrane Domain Core of HIV-1 Vpu Inhibits Its Anti-Tetherin Activity

    Article • PLOS One, June 2011, PLOS

    Professor Ralph A Tripp

  175. Comparative Pathology in Ferrets Infected with H1N1 Influenza A Viruses Isolated from Different Hosts

    Article • Journal of Virology, May 2011, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  176. Comparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1)

    Article • Virology, May 2011, Elsevier

    Professor Ralph A Tripp

  177. Universal Oligonucleotide Microarray for Sub-Typing of Influenza A Virus

    Article • PLOS One, April 2011, PLOS

    Professor Ralph A Tripp

  178. Comparative Pathogenesis of Three Human and Zoonotic SARS-CoV Strains in Cynomolgus Macaques

    Article • PLOS One, April 2011, PLOS

    Professor Ralph A Tripp

  179. Viral and Atypical Bacterial Detection in Acute Respiratory Infection in Children Under Five Years

    Article • PLOS One, April 2011, PLOS

    Professor Ralph A Tripp

  180. Aerosol Inoculation with a Sub-lethal Influenza Virus Leads to Exacerbated Morbidity and Pulmonary Disease Pathogenesis

    Article • Viral Immunology, April 2011, Mary Ann Liebert Inc

    Stephen Mark Tompkins, Professor Ralph A Tripp

  181. Distinct Roles of Cdc42 in Thymopoiesis and Effector and Memory T Cell Differentiation

    Article • PLOS One, March 2011, PLOS

    Professor Ralph A Tripp

  182. Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice

    Article • Vaccine, March 2011, Elsevier

    Stephen Mark Tompkins, Professor Ralph A Tripp

  183. A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells

    Article • PLOS One, February 2011, PLOS

    Professor Ralph A Tripp

  184. Serological Response to the 2009 Pandemic Influenza A (H1N1) Virus for Disease Diagnosis and Estimating the Infection Rate in Thai Population

    Article • PLOS One, January 2011, PLOS

    Professor Ralph A Tripp

  185. Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds

    Article • PLOS One, January 2011, PLOS

    Professor Ralph A Tripp

  186. One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles

    Article • The Analyst, January 2011, Royal Society of Chemistry

    Stephen Mark Tompkins, Professor Ralph A Tripp

  187. Passage of low-pathogenic avian influenza (LPAI) viruses mediates rapid genetic adaptation of a wild-bird isolate in poultry

    Article • Archives of Virology, January 2011, Springer Science + Business Media

    Stephen Mark Tompkins, Professor Ralph A Tripp

  188. Application of RNA Interference to Viral Diseases

    Article • November 2010, Wiley

    Stephen Mark Tompkins, Professor Ralph A Tripp

  189. Effects of Human Respiratory Syncytial Virus, Metapneumovirus, Parainfluenza Virus 3 and Influenza Virus on CD4+ T Cell Activation by Dendritic Cells

    Article • PLOS One, November 2010, PLOS

    Professor Ralph A Tripp

  190. Rabies Virus Expressing Dendritic Cell-Activating Molecules Enhances the Innate and Adaptive Immune Response to Vaccination

    Article • Journal of Virology, November 2010, ASM Journals

    Professor Ralph A Tripp

  191. Exploring Cell Tropism as a Possible Contributor to Influenza Infection Severity

    Article • PLOS One, November 2010, PLOS

    Dr Hana Maria Dobrovolny, Professor Ralph A Tripp

  192. Detection of Mycoplasma pneumoniae in Simulated and True Clinical Throat Swab Specimens by Nanorod Array-Surface-Enhanced Raman Spectroscopy

    Article • PLOS One, October 2010, PLOS

    Professor Ralph A Tripp

  193. A Metagenomic Analysis of Pandemic Influenza A (2009 H1N1) Infection in Patients from North America

    Article • PLOS One, October 2010, PLOS

    Professor Ralph A Tripp

  194. Therapeutic targeting of respiratory syncytial virus G-protein

    Article • Immunotherapy, September 2010, Future Medicine

    Professor Ralph A Tripp

  195. Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin

    Article • PLOS One, September 2010, PLOS

    Professor Ralph A Tripp

  196. The Expression of Vasoactive Intestinal Peptide Receptor 1 Is Negatively Modulated by MicroRNA 525-5p

    Article • PLOS One, August 2010, PLOS

    Professor Ralph A Tripp, Professor Rosa Sorrentino

  197. Monomeric and Dimeric CXCL8 Are Both Essential for In Vivo Neutrophil Recruitment

    Article • PLOS One, July 2010, PLOS

    Professor Ralph A Tripp

  198. Innate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins

    Article • PLOS One, July 2010, PLOS

    Professor Ralph A Tripp

  199. Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice

    Article • Journal of Virology, June 2010, ASM Journals

    Professor Ralph A Tripp

  200. The Proapoptotic Influenza A Virus Protein PB1-F2 Forms a Nonselective Ion Channel

    Article • PLOS One, June 2010, PLOS

    Professor Ralph A Tripp

  201. Trafficking of Sendai Virus Nucleocapsids Is Mediated by Intracellular Vesicles

    Article • PLOS One, June 2010, PLOS

    Professor Ralph A Tripp

  202. A Single Immunization with Soluble Recombinant Trimeric Hemagglutinin Protects Chickens against Highly Pathogenic Avian Influenza Virus H5N1

    Article • PLOS One, May 2010, PLOS

    Professor Ralph A Tripp

  203. Phospholipase D1 Mediates TNFα-Induced Inflammation in a Murine Model of TNFα-Induced Peritonitis

    Article • PLOS One, May 2010, PLOS

    Professor Ralph A Tripp

  204. Rapid and Sensitive Detection of Rotavirus Molecular Signatures Using Surface Enhanced Raman Spectroscopy

    Article • PLOS One, April 2010, PLOS

    Professor Ralph A Tripp

  205. Respiratory Syncytial Virus F and G Proteins Induce Interleukin 1α, CC, and CXC Chemokine Responses by Normal Human Bronchoepithelial Cells

    Article • The Journal of Infectious Diseases, April 2010, Oxford University Press (OUP)

    Professor Ralph A Tripp

  206. SERS-based viral fingerprinting: current capabilities and challenges

    Article • April 2010, SPIE

    Professor Ralph A Tripp

  207. Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)

    Article • PLOS One, April 2010, PLOS

    Professor Ralph A Tripp

  208. Pneumovirus and Metapneumovirus: Respiratory Syncytial Virus and Human Metapneumovirus

    Article • March 2010, Wiley

    Professor Ralph A Tripp

  209. Identification of individual genotypes of measles virus using surface enhanced Raman spectroscopy

    Article • The Analyst, January 2010, Royal Society of Chemistry

    Professor Ralph A Tripp

  210. Label-free SERS detection of microRNA based on affinity for an unmodified silver nanorod array substrate

    Article • Chemical Communications, January 2010, Royal Society of Chemistry

    Professor Ralph A Tripp

  211. Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice

    Article • Journal of Virology, October 2009, ASM Journals

    Professor Ralph A Tripp

  212. Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients

    Article • The Journal of Immunology, October 2009, The American Association of Immunologists

    Professor Ralph A Tripp

  213. Quantitative Surface-Enhanced Raman Spectroscopy Based Analysis of MicroRNA Mixtures

    Article • Applied Spectroscopy, October 2009, SAGE Publications

    Professor Ralph A Tripp

  214. Emerging Technologies in Nanotechnology-Based Pathogen Detection

    Article • Clinical Microbiology Newsletter, September 2009, Elsevier

    Professor Ralph A Tripp

  215. Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

    Article • The Journal of Infectious Diseases, August 2009, Oxford University Press (OUP)

    Professor Ralph A Tripp

  216. Fabrication and characterization of a multiwell array SERS chip with biological applications

    Article • Biosensors and Bioelectronics, August 2009, Elsevier

    Professor Ralph A Tripp

  217. Replication and pathogenesis associated with H5N1, H5N2, and H5N3 low-pathogenic avian influenza virus infection in chickens and ducks

    Article • Archives of Virology, July 2009, Springer Science + Business Media

    Stephen Mark Tompkins, Professor Ralph A Tripp

  218. RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy

    Article • Antimicrobial Agents and Chemotherapy, June 2009, ASM Journals

    Professor Ralph A Tripp

  219. Respiratory Syncytial Virus Proteins Modulate Suppressors of Cytokine Signaling 1 and 3 and the Type I Interferon Response to Infection by a Toll-Like Receptor Pathway

    Article • Viral Immunology, June 2009, Mary Ann Liebert Inc

    Professor Ralph A Tripp

  220. Optimization of a multi-well array SERS chip

    Article • May 2009, SPIE

    Professor Ralph A Tripp

  221. Human Metapneumovirus Establishes Persistent Infection in the Lungs of Mice and Is Reactivated by Glucocorticoid Treatment

    Article • Journal of Virology, April 2009, ASM Journals

    Professor Ralph A Tripp

  222. The host response and molecular pathogenesis associated with respiratory syncytial virus infection

    Article • Future Microbiology, April 2009, Future Medicine

    Professor Ralph A Tripp

  223. Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice

    Article • Journal of General Virology, March 2009, Society for General Microbiology

    Professor Ralph A Tripp

  224. Therapeutic Applications of RNAi for Silencing Virus Replication

    Article • January 2009, Springer Science + Business Media

    Stephen Mark Tompkins, Professor Ralph A Tripp

  225. Animal Models for Evaluation of Influenza Vaccines

    Article • January 2009, Springer Science + Business Media

    Stephen Mark Tompkins, Professor Ralph A Tripp

  226. Spherical and Anisotropic Silver Nanomaterials in Medical Diagnosis

    Article • December 2008, Wiley

    Professor Ralph A Tripp

  227. Rapid microRNA (miRNA) detection and classification via surface-enhanced Raman spectroscopy (SERS)

    Article • Biosensors and Bioelectronics, December 2008, Elsevier

    Professor Ralph A Tripp

  228. Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2

    Article • Journal of Virology, November 2008, ASM Journals

    Professor Ralph A Tripp

  229. Revised model for early memory T-cell protection against respiratory virus challenge

    Article • Future Virology, November 2008, Future Medicine

    Professor Ralph A Tripp

  230. Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15)

    Article • Virology Journal, October 2008, Springer Science + Business Media

    Professor Ralph A Tripp

  231. RNA Interference Inhibits Respiratory Syncytial Virus Replication and Disease Pathogenesis without Inhibiting Priming of the Memory Immune Response

    Article • Journal of Virology, September 2008, ASM Journals

    Professor Ralph A Tripp

  232. Virally Encoded MicroRNA (miRNA) Candidates for Gene Silencing

    Article • July 2008, Taylor & Francis

    Stephen Mark Tompkins, Professor Ralph A Tripp

  233. Molecular and cellular mechanisms in the viral exacerbation of asthma

    Article • Microbes and Infection, July 2008, Elsevier

    Professor Ralph A Tripp

  234. Novel nanostructures for SERS biosensing

    Article • Nano Today, June 2008, Elsevier

    Professor Ralph A Tripp

  235. Infectious Agent Detection With SERS-Active Silver Nanorod Arrays Prepared by Oblique Angle Deposition

    Article • IEEE Sensors Journal, June 2008, Institute of Electrical & Electronics Engineers (IEEE)

    Professor Ralph A Tripp

  236. An Au/Si hetero-nanorod-based biosensor forSalmonelladetection

    Article • Nanotechnology, March 2008, Institute of Physics Publishing

    Professor Ralph A Tripp

  237. Identification and classification of respiratory syncytial virus (RSV) strains by surface-enhanced Raman spectroscopy and multivariate statistical techniques

    Article • Analytical and Bioanalytical Chemistry, January 2008, Springer Science + Business Media

    Professor Ralph A Tripp

  238. Serum Mannose-Binding Lectin Levels are Linked with Respiratory Syncytial Virus (RSV) Disease

    Article • Journal of Clinical Immunology, October 2007, Springer Science + Business Media

    Professor Ralph A Tripp

  239. Evasion of Host Immune Responses by Tumours and Viruses

    Article • September 2007, Wiley

    Professor Ralph A Tripp

  240. Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge

    Article • Virology, May 2007, Elsevier

    Stephen Mark Tompkins, Professor Ralph A Tripp

  241. Bioconjugated nanoparticle detection of respiratory syncytial virus infection

    Article • International Journal of Nanomedicine, March 2007, Dove Medical Press

    Professor Ralph A Tripp

  242. An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection

    Article • Immunology and Cell Biology, January 2007, Wiley

    Professor Ralph A Tripp

  243. Rapid and Sensitive Detection of Respiratory Virus Molecular Signatures Using a Silver Nanorod Array SERS Substrate

    Article • Nano Letters, November 2006, American Chemical Society (ACS)

    Professor Ralph A Tripp

  244. Silver nanorod arrays as highly sensitive SERS substrates for viral detection

    Article • August 2006, SPIE

    Professor Ralph A Tripp

  245. Counting Single Native Biomolecules and Intact Viruses with Color-Coded Nanoparticles

    Article • Analytical Chemistry, January 2006, American Chemical Society (ACS)

    Professor Ralph A Tripp

  246. Respiratory Syncytial Virus (RSV) Infects Neuronal Cells and Processes That Innervate the Lung by a Process Involving RSV G Protein

    Article • Journal of Virology, January 2006, ASM Journals

    Professor Ralph A Tripp

  247. Perspective on the host response to human metapneumovirus infection: what can we learn from respiratory syncytial virus infections?

    Article • Microbes and Infection, January 2006, Elsevier

    Professor Ralph A Tripp

  248. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins

    Article • Journal of Virological Methods, September 2005, Elsevier

    Professor Ralph A Tripp

  249. Cytokines and Respiratory Syncytial Virus Infection

    Article • Proceedings of the American Thoracic Society, August 2005, American Thoracic Society

    Professor Ralph A Tripp

  250. Real-Time Detection of Virus Particles and Viral Protein Expression with Two-Color Nanoparticle Probes

    Article • Journal of Virology, July 2005, ASM Journals

    Professor Ralph A Tripp

  251. The Immune Response to Human Metapneumovirus Is Associated with Aberrant Immunity and Impaired Virus Clearance in BALB/c Mice

    Article • Journal of Virology, May 2005, ASM Journals

    Professor Ralph A Tripp

  252. Corrigendum to “Serological cross-reactivity of members of the Metapneumovirus genus” [Virus Res. 105 (2004) 67–73]

    Article • Virus Research, January 2005, Elsevier

    Professor Ralph A Tripp

  253. Human Metapneumovirus Persists in BALB/c Mice despite the Presence of Neutralizing Antibodies

    Article • Journal of Virology, December 2004, ASM Journals

    Professor Ralph A Tripp

  254. Anti–G Protein Antibody Responses to Respiratory Syncytial Virus Infection or Vaccination Are Associated with Inhibition of G Protein CX3C‐CX3CR1 Binding and Leukocyte Chemotaxis

    Article • The Journal of Infectious Diseases, December 2004, Oxford University Press (OUP)

    Professor Ralph A Tripp

  255. Serological cross-reactivity of members of the Metapneumovirus genus

    Article • Virus Research, September 2004, Elsevier

    Professor Ralph A Tripp

  256. Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles

    Article • Vaccine, June 2004, Elsevier

    Professor Ralph A Tripp

  257. Pathogenesis of Respiratory Syncytial Virus Infection

    Article • Viral Immunology, June 2004, Mary Ann Liebert Inc

    Professor Ralph A Tripp

  258. The Brume Surrounding Respiratory Syncytial Virus Persistence

    Article • American Review of Respiratory Disease, April 2004, American Thoracic Society

    Professor Ralph A Tripp

  259. Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness

    Article • Journal of Allergy and Clinical Immunology, November 2003, Elsevier

    Professor Ralph A Tripp, Dr Matti E Waris

  260. Enhanced Disease and Pulmonary Eosinophilia Associated with Formalin-Inactivated Respiratory Syncytial Virus Vaccination Are Linked to G Glycoprotein CX3C-CX3CR1 Interaction and Expression of Substance P

    Article • Journal of Virology, September 2003, ASM Journals

    Professor Ralph A Tripp

  261. CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice

    Article • Vaccine, June 2003, Elsevier

    Professor Ralph A Tripp

  262. The G Glycoprotein of Respiratory Syncytial Virus Depresses Respiratory Rates through the CX3C Motif and Substance P

    Article • Journal of Virology, June 2003, ASM Journals

    Professor Ralph A Tripp

  263. Role of Cytokines in the Development and Maintenance of Memory T Cells During Respiratory Viral Infection

    Article • Current Pharmaceutical Design, January 2003, Bentham Science Publishers

    Professor Ralph A Tripp

  264. Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection

    Article • Journal of Neuroimmunology, August 2002, Elsevier

    Professor Ralph A Tripp

  265. Neutralizing Anti-F Glycoprotein and Anti-Substance P Antibody Treatment Effectively Reduces Infection and Inflammation Associated with Respiratory Syncytial Virus Infection

    Article • Journal of Virology, July 2002, ASM Journals

    Professor Ralph A Tripp

  266. Peripheral Blood Mononuclear Cells from Infants Hospitalized Because of Respiratory Syncytial Virus Infection Express T Helper–1 and T Helper–2 Cytokines and CC Chemokine Messenger RNA

    Article • The Journal of Infectious Diseases, May 2002, Oxford University Press (OUP)

    Professor Ralph A Tripp

  267. The Failure of Interleukin-10–deficient Mice to Develop Airway Hyperresponsiveness Is Overcome by Respiratory Syncytial Virus Infection in Allergen–sensitized/challenged Mice

    Article • American Review of Respiratory Disease, March 2002, American Thoracic Society

    Professor Ralph A Tripp

  268. Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus

    Article • Journal of Virology, November 2001, ASM Journals

    Professor Ralph A Tripp

  269. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

    Article • Nature Immunology, August 2001, Springer Science + Business Media

    Professor Ralph A Tripp

  270. 75th birthday of Professor Ralph Stock

    Article • Chromatographia, March 2001, Springer Science + Business Media

    Professor Ralph A Tripp

  271. CD4+ T Cell Frequencies and Th1/Th2 Cytokine Patterns Expressed in the Acute and Memory Response to Respiratory Syncytial Virus I-Ed-Restricted Peptides

    Article • Cellular Immunology, January 2001, Elsevier

    Professor Ralph A Tripp

  272. Respiratory Syncytial Virus G and/or SH Glycoproteins Modify CC and CXC Chemokine mRNA Expression in the BALB/c Mouse

    Article • Journal of Virology, July 2000, ASM Journals

    Professor Ralph A Tripp

  273. TH1- AND TH2-TYPE CYTOKINE EXPRESSION BY ACTIVATED TLYMPHOCYTES FROM THE LUNG AND SPLEEN DURING THE INFLAMMATORY RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS

    Article • Cytokine, June 2000, Elsevier

    Professor Ralph A Tripp

  274. Respiratory Syncytial Virus Infection and G and/or SH Protein Expression Contribute to Substance P, Which Mediates Inflammation and Enhanced Pulmonary Disease in BALB/c Mice

    Article • Journal of Virology, February 2000, ASM Journals

    Professor Ralph A Tripp

  275. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells

    Article • Nature, April 1998, Springer Science + Business Media

    Professor Ralph A Tripp

  276. Influenza Virus (Orthomyxovirus), Infection and Immunity

    Article • January 1998, Elsevier

    Professor Ralph A Tripp

  277. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections

    Article • Immunological Reviews, October 1997, Wiley

    Professor Ralph A Tripp

  278. Tuning into immunological dissonance: an experimental model for infectious mononucleosis

    Article • Current Opinion in Immunology, August 1997, Elsevier

    Professor Ralph A Tripp

  279. Pathogenesis of an Infectious Mononucleosis-like Disease Induced by a Murine γ-Herpesvirus: Role for a Viral Superantigen?

    Article • Journal of Experimental Medicine, May 1997, Rockefeller University Press

    Professor Ralph A Tripp

  280. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells

    Article • Nature, July 1996, Springer Science + Business Media

    Professor Ralph A Tripp

  281. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene

    Article • Nature, April 1996, Springer Science + Business Media

    Professor Ralph A Tripp

  282. Establishment and Persistence of Virus-Specific CD4+ and CD8+ T Cell Memory

    Article • Immunological Reviews, April 1996, Wiley

    Professor Ralph A Tripp

  283. CD8+ T-cell memory to viruses

    Article • Current Opinion in Immunology, August 1994, Elsevier

    Professor Ralph A Tripp

  284. Cortisol mediated suppression of salmonid lymphocyte responses invitro

    Article • Developmental & Comparative Immunology, June 1987, Elsevier

    Professor Ralph A Tripp